WZWenying Zhong

Wenying Zhong

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Wenying Zhong has a total of 174 co-authors. Here are the top co-authors by number of shared publications:

  • Keming Xu

    Department of Chemistry, China Pharmaceutical University, Nanjing 210009, China; Key Laboratory of Biomedical Functional Materials, China Pharmaceutical University, Nanjing 210009, China

    32 shared publications
  • Can Wu

    Department of Chemistry, China Pharmaceutical University, Nanjing 210009, China; School of Pharmacy, Henan University of Chinese Medicine, Zhengzhou 450046, China

    14 shared publications
  • Yaxin Zheng

    Department of Chemistry, China Pharmaceutical University, Nanjing 210009, China

    13 shared publications
  • Chang Shu

    Department of Analytical Chemistry, China Pharmaceutical University, Nanjing, China

    11 shared publications
  • Shuyao Zhou

    Department of Chemistry, China Pharmaceutical University, Nanjing 210009, China

    10 shared publications
  • Tingting Zhang

    Department of Chemistry

    9 shared publications

Latest Publications

  • Core‐Shell Microneedles for Sequential Delivery of Antibacterial, Antioxidant, and Anti‐Inflammatory Agents in Infected Wound Healing

    by Yuanyuan Liu, Qiling Jin, Yangfei Shen, Yanqun Wu, Wenwen Lei, Qiqi Luo, Wenying Zhong, Keming Xu

    Infected wounds are dynamic pathological processes that progress through acute, chronic, and repair phases, each with distinct therapeutic requirements. Conventional treatments, which release all drugs simultaneously, often fail to meet these stage‐specific needs. In this study, we develop a multifunctional core‐shell microneedle (MN) system capable of sequential delivery of different therapeutics to address the requirements of various healing stages. During the acute phase, the shell composed of gelatin‐hydroxyphenylalanine (Gtn‐HPA) hydrogel rapidly releases bacitracin (Bac), thereby inhibiting bacterial proliferation. During the chronic phase, MMP9‐responsive peptide nanoparticles (INM‐1@EDA) within the MN core undergo enzymatic cleavage, releasing the edaravone (EDA) and indomethacin (INM) moieties to exert antioxidant and anti‐inflammatory activities, respectively. During the repair phase, the residual gelatin at the site supports keratinocyte proliferation and migration, promoting skin tissue regeneration. In a mouse wound model with Staphylococcus aureus infection, core‐shell MN treatment achieves nearly complete wound closure in 12 days (96.7 ± 1.3%) with markedly reduced bacterial burden and decreased inflammatory cytokine levels. This MN system achieves sequential release of antibacterial, anti‐inflammatory, and antioxidant therapeutics based on wound microenvironments, offering new strategies for efficacious treatment of infected wounds.

  • NIR-Activated Enteric Prodrug Microparticles for Bioimaging-Guided Chemotherapy of Colorectal Cancer

    by Lei Zhou, Yue Fei, Ziyi Wang, Xiaohui Wang, Luya Zhu, Furong Zhao, Ni Duan, Yixuan Wang, Jing Wang, Wenying Zhong, et al.

    Colorectal cancer (CRC) remains a leading cause of cancer mortality worldwide. 5-Fluorouracil (5-FU) is a first-line chemotherapeutic widely used in CRC treatment, but its systemic administration often causes severe toxicity due to uncontrolled biodistribution. Herein, we present near-infrared (NIR)-activated enteric prodrug microparticles, HPMCP@L-UCNPs-ONB-5-FU, which enable spatiotemporally controlled release of 5-FU in the colon. The photocleavable prodrug o-nitrobenzyl-5-fluorouracil (ONB-5-FU) is conjugated to large upconversion nanoparticles (L-UCNPs) and encapsulated within the enteric polymer hydroxypropyl methylcellulose phthalate (HPMCP) to resist gastric degradation. After oral administration, low-power 980 nm excitation yields 800 nm emission for bioimaging, whereas high-power excitation generates strong 365 nm emission that cleaves the ONB linker and locally releases active 5-FU. In vitro studies confirmed light-gated and power-dependent drug release, while cellular and orthotopic CRC studies demonstrated potent tumor inhibition with minimal systemic toxicity. Overall, this work establishes a precise and biocompatible NIR-controlled prodrug activation paradigm for oral chemotherapy of CRC.

  • Spatiotemporally Controlled Lysosomal Membrane Permeabilization Amplifies STING‐Driven Antitumor Immunity in Prostate Cancer

    by Qishu Jiao, Jiaqi Zhang, Chunlu Wang, Zhaohan Liu, Yongming Jia, Jia Chen, Kui Wang, Shicheng Pei, Wenying Zhong, Ji Zheng

    Prostate cancer (PCa) remains a major clinical challenge due to therapeutic resistance and immunologically cold tumor microenvironment. Lysosomal membrane permeabilization (LMP)–induced lysosome‐dependent cell death offers an alternative route to eliminate resistant tumor cells and initiate immunogenic cell death, yet its efficacy is often limited by insufficient spatiotemporal control and immune activation. Here, we report a spatiotemporally programmable supramolecular nanoplatform (Cu‐P‐MSA) that integrates lysosome‐targeted sonodynamic therapy with tumor‐confined innate immune activation for PCa treatment. Cu‐P‐MSA is a modular self‐assembling peptide incorporating a PSMA‐targeting ligand, morpholine moiety, and cathepsin B–cleavable linker, enabling tumor‐selective uptake and in situ formation of fibrous sonosensitizer depots within lysosomes. Upon ultrasound irradiation, a glutathione‐responsive open‐shell sonosensitizer induces controlled LMP, simultaneously activating ferroptosis and pyroptosis and promoting immunogenic cell death. Meanwhile, tumor‐specific release of a STING agonist MSA‐2 elicits robust type I interferon responses, driving dendritic cell maturation and cytotoxic T‐cell infiltration. This coordinated lysosomal disruption–immune amplification strategy effectively reprograms the tumor immune microenvironment and suppresses both primary and distant tumors, with inhibition rates reaching 84.3% and 77.5%, respectively. Overall, this work establishes a spatiotemporally controlled supramolecular approach that integrates lysosomal disruption with innate immune activation to overcome therapeutic resistance and immunosuppression in PCa.

  • A Dual-Channel NIR Fluorescent Probe for Self-Calibrated Ratiometric Imaging and In Vivo Discrimination of Malignant Tumors via Alkaline Phosphatase Activity

    by Xiaoping Chen, Zhaohan Liu, Wenwen Lei, Min Su, Tingting Zhang, Xiaoxing Wu, Wenying Zhong, Keming Xu

    Alkaline phosphatase (ALP) is a well-established biomarker of tumor malignancy, yet the precise quantification and spatial mapping of its activity in living systems remain challenging with conventional single-channel probes. Herein, we report a rationally designed dual-channel near-infrared (NIR) fluorescent probe, P-CyBr-NBD, for ratiometric imaging and in vivo discrimination of tumors based on ALP activity. The probe integrates a NIR-emitting hemicyanine unit (CyBr) with a green-emitting fluorophore (NBD), which serve as the ALP-responsive signal and internal reference, respectively. Upon ALP-mediated dephosphorylation, the NIR signal of CyBr at 730 nm shows a marked fluorescence increase, while the green emission of NBD at 545 nm remains essentially constant, enabling self-calibrated ratiometric quantification of ALP activity via the fluorescence ratio (FI730nm/FI545nm). Encapsulation within lipid nanomicelles facilitates efficient cellular uptake and affords excellent specificity with minimal cytotoxicity. The dual-channel platform successfully distinguished ALP-high tumor cells (HeLa and HepG2) from ALP-low melanoma cells (B16F10) and normal cells (NIH3T3) by confocal imaging. In xenograft mouse models bearing HeLa or B16F10 tumors, ratiometric fluorescence imaging revealed a significantly higher signal ratio in HeLa tumors, enabling clear discrimination based on endogenous ALP activity. The probe exhibited selective activation and prolonged retention in ALP-overexpressing HeLa tumors, underscoring its potential for precise in vivo tumor imaging and enzymatic activity profiling. This work establishes a generalizable strategy for high-fidelity ratiometric enzymatic sensing and provides a useful tool for cancer diagnostics and microenvironmental analysis.


  • Endoplasmic reticulum-targeted photodynamic therapy synergizes with rapamycin to induce autophagic cancer cell death

    by Yaxin Zheng, Min Su, Shuyao Zhou, Tingting Zhang, Yanqun Wu, Keming Xu, Wenying Zhong


  • Silent-To-Bright CTCs-Hitchhiking Peptide Nanoprobe for Activatable NIR Imaging of Lung Metastasis in Mice

    by Tingting Zhang, Xiaoping Chen, Shiqi Hao, Yufan Qin, Qiqi Luo, Ran Yan, Wenying Zhong, Keming Xu

    Metastasis remains the leading cause of cancer-related mortality, yet its early detection is hindered by the subtle and unpredictable nature of the metastatic niche. In this study, we developed a self-assembling peptide-based activatable nanoprobe, 1-CyBr(PBA)-NGR NPs, designed for the early detection of the metastatic niche through circulating tumor cells (CTCs)-mediated hitchhiking and hydrogen peroxide (H2O2)-induced fluorescence activation. The peptide probe spontaneously assembled into stable spherical nanoparticles in aqueous media and undergoes H2O2-triggered fluorescence recovery via oxidation of the phenylboronic acid masking group. Upon intravenous injection, 1-CyBr(PBA)-NGR NPs “hitchhike” CTCs through specific binding via the NGR moiety, utilizing the natural trafficking pathways of CTCs to reach the metastatic lesion. Upon reaching the metastatic site, the nanoparticles are selectively activated by the microenvironment, resulting in fluorescence activation and enabling precise optical imaging of the metastatic site. In vivo imaging in a lung metastatic mouse model revealed distinct fluorescence in the lungs following intravenous administration of 1-CyBr(PBA)-NGR NPs, whereas minimal fluorescence was observed in both the healthy control and antioxidant N-acetylcysteine (NAC)-treated metastatic mice, further confirming the probe’s selective activation in response to the elevated H2O2 levels in the metastatic lesion. This study presents a “silent-to-bright” NIR imaging strategy for tumor metastasis monitoring, utilizing CTCs as “hitchhiking” carriers and the metastatic microenvironment as fluorescence activators, offering a promising approach for tumor metastasis diagnosis and intervention.

  • Open Access

    Phonon Structure Engineering for Intrinsically Spectrally Selective Emitters by Anion Groups

    by Rui Zhang, Enhui Huang, Wenying Zhong, Bo Xu

    Spectrally selective emitters (SSEs) have attracted considerable attention, because of radiative cooling, which could dissipate the heat from earth to outer space through the atmospheric window without any energy input. Intrinsically inorganic SSEs have significant advantages to other SSEs, such as the low fabrication cost due to the extremely simple structures and long life span under solar exposure. However, few inorganic materials can act as intrinsic SSEs due to the limited emissions in the atmospheric window. Here, we propose a strategy to design intrinsic SSEs by complementing the IR-active phonons in atmospheric window with anion groups. Accordingly, we demonstrate borates containing both [BO3]3− and [BO4]5− units can exhibit high emissivity within the whole atmospheric window, because the IR-active phonons of [BO3]3− units usually locate around 8 and 13 μm, while those of [BO4]5− units distribute in 9~11 μm. Furthermore, K3B6O10Cl and BaAlBO4 are selected as two examples to display their near-unity emissivity (>95%) within the whole atmospheric window experimentally. These results not only offer a new strategy for the design of intrinsic SSEs, but also endow wide band-gap borates containing both [BO3]3− and [BO4]5− units with great potential applications for radiative cooling.

  • Quantitative Near-Infrared Photoacoustic Imaging of Gamma-Glutamyl Transpeptidase Activity in Tumors

    by Yueyan Yang, Rui Wang, Xinrun Jin, Wenying Zhong, Lei Zhou

    Gamma-glutamyl transpeptidase (GGT) is essential for glutathione metabolism and is overexpressed in many cancers, making its sensitive and quantitative detection crucial for early cancer diagnosis. However, existing imaging strategies often lack sufficient sensitivity and accuracy. Herein, we present a near-infrared (NIR), ratiometric photoacoustic nanoprobe (Au NR@PEG@IR775-PEI@PBEAGA) for quantitative GGT detection. This nanoprobe is fabricated by sequential coating Au nanorod (Au NR) with polyethylene glycol (PEG), IR775-doped polyethylenimine (PEI), and GGT-responsive polymer, poly-2-(L-γ-glutamyl-L-α-aminobutyrylamino)ethyl acrylamide (PBEAGA). It has dual photoacoustic signals at 775 and 930 nm; upon GGT cleavage, IR775 is released, reducing the 775 nm signal while the 930 nm signal remains an internal reference. The ratiometric readout (PA775/PA930) enables robust GGT quantification with a limit of detection of 0.48 U/mL. In vivo studies showed the real-time tumor imaging and noninvasive assessment of GGT activity. We envision this nanoprobe will be used to diagnose early cancers in the clinic in the future.


  • A Self-Assembling Chimeric Peptide Gear-Set with "Three-in-One" Function for Precision Photodynamic Therapy

    by Qishu Jiao, Tingting Zhang, Shuyao Zhou, Xuan Luo, Shicheng Pei, Yaxin Zheng, Keming Xu, Wenying Zhong